PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30971286-0	2019	Microglial NLRP3 inflammasome activation mediates IL-1beta release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model.	Nitroglycerin	123-136	NLR family, pyrin domain containing 3	Mus musculus	11-16	
30971286-9	2019	RESULTS: Repeated NTG administration induced acute and chronic mechanical hyperalgesia and increased expression of NLRP3 and IL-1beta.	Nitroglycerin	18-21	NLR family, pyrin domain containing 3	Mus musculus	115-120	
30971286-10	2019	Blockade of NLRP3 or IL-1beta reduced NTG-induced hyperalgesia, and this effect was accompanied by a significant inhibition of the NTG-induced increase in p-ERK, c-Fos and CGRP levels in the TNC.	Nitroglycerin	38-41	NLR family, pyrin domain containing 3	Mus musculus	12-17	
30971286-10	2019	Blockade of NLRP3 or IL-1beta reduced NTG-induced hyperalgesia, and this effect was accompanied by a significant inhibition of the NTG-induced increase in p-ERK, c-Fos and CGRP levels in the TNC.	Nitroglycerin	131-134	NLR family, pyrin domain containing 3	Mus musculus	12-17